2026-04-10T19:27:00+01:00
References and support materials for ”Accelerating consistent, stable cell line development with targeted integration”
Zalma V, et al. CHO Cells For Virus-Like Particle And Subunit Vaccine Manufacturing. Vaccine. 2024;42: 2530-2542.
Tihanyi B, Nyitray L. Recent Advances In CHO Cell Line Development For Recombinant Protein Production. Drug Discovery Today: Technologies. 2020;38: 25-34.
WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™ to Accelerate Biologics Development with High Titer and Superior Stability. [Internet] WuXI Biologics. 2025. Available from: https://www.wuxibiologics.com/press-release/wuxi-biologics-launches-wuxia4-targeted-integration-cell-line-platform-truesite-ti-accelerate-biologics-development-with-high-titer-and-superior-stability/
McGovern ĀT, Salisbury C, Nyberg G. The Pandemic and Resilience for the Future: AccBio 2021. Biotechnol. Prog. 2022;38:e3207.
2025-10-15T11:00:00
Sponsored by USP
2026-04-20T10:39:00
Sponsored by Merck
2025-12-11T13:32:00
Sponsored by Hexagon
2025-07-10T12:58:00
Sponsored by FUJIFILM Wako Pure Chemical Corporation
2026-06-16T13:00:00 2026-06-16T14:00:00
2026-05-12T07:43:00
Sponsored by Sartorius, By European Pharmaceutical Review
No comments yet